ScholarIQanswers from OpenAlex

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

PaperCitations, authors & open-access status

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study have?

ScholarIQcitation count

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study has 1,246 citations in the OpenAlex counts ScholarIQ stores.

When was Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study published?

ScholarIQyear

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study has 2008 year in the ScholarIQ index.

What is the open-access status of Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study?

ScholarIQoa status

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study has green oa status in the ScholarIQ index.

What is the DOI of Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study?

ScholarIQdoi

The DOI for Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study is on the source record.

What is the PMID of Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study?

ScholarIQpmid

The PMID for Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study is on the source record.

What is the OpenAlex record for Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study?

ScholarIQopenalex

The OpenAlex for Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial